| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 85.30B | 88.04B | 80.92B | 67.56B | 61.00B | 49.27B |
| Gross Profit | 33.31B | 32.24B | 31.46B | 27.13B | 24.43B | 16.81B |
| EBITDA | 17.59B | 18.59B | 16.73B | 14.20B | 12.42B | 6.25B |
| Net Income | 10.91B | 11.17B | 10.33B | 8.79B | 9.20B | 2.98B |
Balance Sheet | ||||||
| Total Assets | 90.05B | 100.88B | 95.46B | 91.41B | 82.10B | 69.01B |
| Cash, Cash Equivalents and Short-Term Investments | 21.91B | 21.34B | 28.48B | 27.21B | 27.18B | 26.32B |
| Total Debt | 8.73B | 8.65B | 8.74B | 8.76B | 8.79B | 10.20B |
| Total Liabilities | 43.77B | 45.28B | 48.14B | 52.67B | 49.09B | 44.39B |
| Stockholders Equity | 46.28B | 55.59B | 47.32B | 38.73B | 33.01B | 24.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.61B | 4.07B | 3.89B | 3.38B | 7.89B |
| Operating Cash Flow | 0.00 | 4.63B | 6.99B | 5.99B | 4.57B | 8.30B |
| Investing Cash Flow | 0.00 | -8.14B | -3.22B | -2.31B | -1.38B | -507.00M |
| Financing Cash Flow | 0.00 | -3.73B | -2.67B | -3.75B | -2.44B | -1.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥19.13T | 24.82 | 12.80% | 0.78% | 10.40% | 11.67% | |
77 Outperform | ¥374.44B | 23.20 | ― | 1.49% | 8.80% | 8.09% | |
76 Outperform | ¥345.69B | 13.22 | ― | 2.04% | -8.82% | 18.33% | |
72 Outperform | ¥918.94B | 20.14 | 4.03% | 2.25% | 5.36% | -24.06% | |
68 Neutral | ¥477.67B | 34.41 | 5.63% | 2.35% | -3.24% | -36.64% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥1.11T | 15.40 | 2.99% | 2.62% | -4.29% | 75.25% |